Le Lézard
Classified in: Business
Subjects: PDT, JVN

Bridging Finance Inc. Collaborates on New Product With Blackrock Asset Management Canada Limited


TORONTO, Oct. 4, 2019 /CNW/ - Bridging Finance Inc. ("Bridging Finance") is pleased to collaborate with BlackRock Asset Management Canada Limited ("BlackRock") to offer one of the most diversified fund of funds offering of alternative credit in Canada.

"We are extremely pleased and honored to welcome BlackRock to our Bridging Fern Alternative Credit Fund (the "Fund"). As one of the largest asset managers in the world, we look forward to working with BlackRock and bringing this unique investment opportunity to the Canadian retail market", said David Sharpe, Chief Executive Officer of Bridging Finance. "This Fund is a first of its kind in Canada and offers Canadian retail investors the opportunity to gain exposure to certain funds and fund managers that are typically only available to institutional investors", added Mr. Sharpe.

The portfolio of underlying funds has been selected by Bridging Finance in order to provide a unique investment opportunity to investors looking to diversify their alternative investments. The investment objective of the Fund is to generate positive absolute returns while preserving capital and with a low correlation to traditional asset classes.

The Fund is currently available through the IIROC dealer channel on FundSERV for retail investors throughout Canada. The Fund has received commitments for CAD$45MM and plans to raise approximately CAD$450MM more in the following 12 months.

About Bridging Finance Inc.
Established in 2012, Bridging Finance is one of Canada's leading alternative credit investment management firms and currently manages approximately $1.6 billion of assets. Bridging Finance provides middle-market North American companies with alternatives to the financing options offered by traditional lenders. Lending proceeds, typically ranging from $3 million to upwards of $50 million, are used by companies to address needs such as restructuring existing debt, providing working capital for growth, supporting inventory purchases and financing expenditures and acquisitions/buyouts. For more information, please visit bridgingfinance.ca.

The units of the Bridging Fern Alternative Credit Fund (the "Units") are not qualified for sale to the public under applicable Canadian securities laws and, accordingly, any offer and sale of the Units in Canada are made on a basis that is exempt from the prospectus requirements of such securities laws and only through registered dealers.

This news release shall not constitute an offer to sell the Units or the solicitation of an offer to buy the Units, nor will there be any sale of the Units, in any jurisdiction where such offer, solicitation or sale is not permitted.

SOURCE Bridging Finance Inc.


These press releases may also interest you

at 16:05
Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced financial results for the full year ended December 31, 2023, and provided an overview of recent developments....

at 16:05
Danimer Scientific, Inc. ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its fourth quarter and full year, ended...

at 16:05
EACO Corporation today reported the results for its quarter ended February 29, 2024. Net sales, net income and earnings per share were as follows for the three months ended February 29, 2024 (dollars in thousands, except per share information):...

at 16:05
CVD Equipment Corporation , today announced its financial results for the fourth quarter and fiscal year ended December 31, 2023. Manny Lakios, President and CEO of CVD Equipment Corporation, commented, "Fourth quarter 2023 revenue was $4.1...

at 16:05
Leafly Holdings, Inc. ("Leafly" or "the Company") , a leading online cannabis discovery marketplace and resource for cannabis consumers, today announced financial results for its fourth quarter and year ended December 31, 2023. "We saw continued...

at 16:05
Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced results for the quarter and full year ended December...



News published on and distributed by: